Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 986.06 million compared to CNY 900.28 million a year ago. Revenue was CNY 994.1 million compared to CNY 908.34 million a year ago.

Net income was CNY 178.27 million compared to CNY 139.83 million a year ago. Basic earnings per share from continuing operations was CNY 0.3843 compared to CNY 0.3026 a year ago. Diluted earnings per share from continuing operations was CNY 0.3843 compared to CNY 0.3026 a year ago.